Baxter International Inc.

BAX ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $126.0M $-15.0M $-1.13B $-46.0M $91.0M $126.0M $-512.0M $140.0M
Depreciation & Amortization $239.0M $237.0M $240.0M $237.0M $257.0M $247.0M $245.0M $254.0M
Depreciation $94.0M $91.0M $95.0M $90.0M $106.0M $92.0M $91.0M $95.0M
Amortization $145.0M $146.0M $145.0M $147.0M $151.0M $155.0M $154.0M $159.0M
Stock-Based Compensation $33.0M $10.0M $37.0M $35.0M $35.0M $10.0M $39.0M $38.0M
Net Cash from Operating Activities $285.0M $213.0M $584.0M $237.0M $217.0M $-193.0M $488.0M $253.0M
Investing Activities
Capital Expenditures — — — — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-117.0M $-133.0M $-198.0M $-111.0M $-115.0M $3.27B $-205.0M $-164.0M
Financing Activities
Dividends Paid $5.0M $5.0M $87.0M $87.0M $87.0M $87.0M $147.0M $148.0M
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $-31.0M $-11.0M $-147.0M $-81.0M $-762.0M $-3.23B $141.0M $-146.0M
Net Change in Cash $137.0M $51.0M $240.0M $40.0M $-608.0M $-118.0M $334.0M $-16.0M
Free Cash Flow — — — — — — — —
← Newer Page 1 of 9 Older →